Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Trinity Biotech plc (NASDAQ: TRIB)
TRIB Stock Predictions and Ratings
WSX Rating:
SELL
WSX Forecast (1yr):
-5.40%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
TRIB Stock Analysis
TRIB
PE Ratio:
TRIB
PEG Ratio:
Not Available
TRIB
Forward EPS Growth (12 month):
0.00%
TRIB
PS Ratio:
0.2
TRIB
PSG Ratio:
Not Available
TRIB
Forward Revenue Growth (12 month):
0.00%
TRIB Articles
No data was found